Items Tagged ‘Esophageal Cancer’

February 13, 2018

Keytruda Promising in PD-L1 Esophageal Cancer

By

CancerConnect News: The checkpoint inhibitor Keytruda (pembrolizumab) has been reported to produce an overall response rate of 30% in patients with PD-L1–positive, advanced esophageal cancer.1 About Keytruda Keytruda is a monoclonal antibody that helps to restore the body’s immune system in fighting cancer. It creates its anti-cancer effects by blocking a specific protein used by cancer […]

View full entry

Tags: checkpoint inhibitor, Esophageal Cancer, gastroesophageal junction cancer, immunotherapy, keytruda, News, pembrolizumab, Precision Cancer Medicine


December 1, 2017

Diagnosed with Esophageal Cancer: 10 Tips on How to Get The Most From Your Doctor

By

1) Choose Your Doctor Carefully Surgeons, medical oncologists and radiation oncologists are the primary doctors involved with esophageal cancer and often work in collaboration. Pick your primary oncologist carefully, rely on people you trust including nurses and other health care professionals who make help with recommendations.  Make sure your doctor is someone you feel comfortable […]

View full entry

Tags: Esophageal Cancer, News


October 3, 2017

New Standard of Care for Treatment of Resectable Gastric Cancer

By

The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at the ESMO 2017 Congress in Madrid.1 Survival in resectable esophago-gastric cancer is poor. Five-year overall survival is around 25% with surgery, and is increased to 36% by […]

View full entry

Tags: Esophageal Cancer, esophago-gastric cancer, Gastric Cancer, News


September 25, 2017

The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer

By

Keytruda (Pembrolizumab) is now indicated for patients with recurrent locally advanced or metastatic gastric or gastro-esophogeal junction adenocarcinoma. Patients eligible for keytruda therapy under this new indication must have PD-L1-expressing tumors, and must demonstrate disease progression after two or more prior lines of therapy – including fluoropyrimidine- and platinum-containing chemotherapy and, in some cases, HER2/neu-targeted […]

View full entry

Tags: checkpoint inhibitor, Esophageal Cancer, Gastric Cancer, gastro-esophogeal junction cancer, keytruda, metastatic gastric, News, pembrolizumab, Precision Cancer Medicine


March 31, 2009

Alcohol-induced Flushing Linked with Esophageal Cancer

By

People who experience facial flushing after consuming alcohol may have an increased risk of developing alcohol-related esophageal cancer. These results were published in PLoS Medicine. Worldwide, an estimated 3.5% of all cancer deaths are attributable to alcohol.[1] Links have been established between alcohol and several types of cancer, including cancers of the mouth, pharynx, larynx, […]

View full entry

Tags: Esophageal Cancer